|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| G01N 33/68 | (2006.01) | ||
| A61P 37/00 | (2006.01) | ||
| A61P 37/02 | (2006.01) |
| (11) | Number of the document | 3491025 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17835436.1 |
| Date of filing the European patent application | 2017-07-31 | |
| (97) | Date of publication of the European application | 2019-06-05 |
| (45) | Date of publication and mention of the grant of the patent | 2023-10-18 |
| (46) | Date of publication of the claims translation | 2023-11-27 |
| (86) | Number | PCT/US2017/044765 |
| Date | 2017-07-31 |
| (87) | Number | WO 2018/023136 |
| Date | 2018-02-01 |
| (30) | Number | Date | Country code |
| 201662368770 P | 2016-07-29 | US | |
| 201662368803 P | 2016-07-29 | US |
| (72) |
LING, Leona, E. , US
ROY, Sucharita , US
WASHBURN, Nathaniel , US
KEHRY, Marilyn , US
KING, David, J. , US
MEADOR, James, III , US
MANNING, Anthony , US
HILLSON, Jan , US
|
| (73) |
Momenta Pharmaceuticals, Inc. ,
1125 Trenton-Harbourton Road, Titusville, NJ 08560,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | FcRn antikūnai ir jų panaudojimo būdai |
| FCRN ANTIBODIES AND METHODS OF USE THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-06-19 | 9 | 208.00 EUR |
| 2026-07-31 |